Stock Rating Upgrade
In recent days the Value Trend Rating for Harrow Health Inc (NASDAQ: HROW) improved from C to B reflecting improving fundamentals and high Appreciation Potential.
Recent Price Action
On 9/5/25, Harrow Health Inc (NASDAQ: HROW) stock enjoyed a large increase of 2.2%, closing at $36.99. However, this advance was accompanied by below average trading volume at 67% of normal. Relative to the market the stock has been strong over the last nine months but has declined -4.6% during the last week.
Current PriceTarget Research Rating
Harrow Health has a current Value Trend Rating of B (Positive). This VT Rating improved in recent days from C previously. With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing inconsistent signals. Harrow Health has a neutral Power Rating of 55 but a good Appreciation Score of 82, leading to the Positive Value Trend Rating.
Be the first to comment